Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127095351 | 12709535 | 1 | I | 20160824 | 20160902 | 20160902 | EXP | US-JNJFOC-20160822999 | JANSSEN | PRABHAKARAN S, PRITCHARD C. COMPARISON OF INFECTION RATES IN PATIENTS RECEIVING DENOSUMAB, DENOSUMAB AND BIOLOGICS AND BIOLOGICS ALONE IN A SUBURBAN RHEUMATOLOGY CLINIC. ARTHRITIS AND RHEUMATOLOGY 2014;66:S409. | 0.00 | Y | 0.00000 | 20160902 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127095351 | 12709535 | 1 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 103772 | LYOPHILIZED POWDER | ||||||||
| 127095351 | 12709535 | 2 | SS | GOLIMUMAB | GOLIMUMAB | 1 | Subcutaneous | U | U | 125289 | SOLUTION FOR INJECTION | ||||||||
| 127095351 | 12709535 | 3 | SS | DENOSUMAB | DENOSUMAB | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127095351 | 12709535 | 4 | SS | TOCILIZUMAB | TOCILIZUMAB | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127095351 | 12709535 | 5 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127095351 | 12709535 | 6 | SS | BELIMUMAB | BELIMUMAB | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127095351 | 12709535 | 7 | SS | ABATACEPT | ABATACEPT | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127095351 | 12709535 | 8 | SS | ADALIMUMAB | ADALIMUMAB | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127095351 | 12709535 | 1 | Product used for unknown indication |
| 127095351 | 12709535 | 2 | Product used for unknown indication |
| 127095351 | 12709535 | 3 | Product used for unknown indication |
| 127095351 | 12709535 | 4 | Product used for unknown indication |
| 127095351 | 12709535 | 5 | Product used for unknown indication |
| 127095351 | 12709535 | 6 | Product used for unknown indication |
| 127095351 | 12709535 | 7 | Product used for unknown indication |
| 127095351 | 12709535 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127095351 | 12709535 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127095351 | 12709535 | Hospitalisation | |
| 127095351 | 12709535 | Infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |